Momenta Pharmaceuticals has tapped Craig Wheeler, the former president of Chiron BioPharmaceuticals, to be its next CEO. Alan Crane, who's stepping down from the post, will stay on the board.
- here's the report on Wheeler from the Boston Globe
ALSO: Fresh from raising $60 million in new venture funds, Prestwick Pharmaceuticals has named George F. Horner III president and CEO. Release
PLUS: Howard D. Goldstein has accepted the top position at Arcxis Biotechnologies, signaling the company's move into commercial development of its technologies for rapid, diagnostic gene and protein identification. Release